Comparison of Two Dosing Regimens of Temozolomide in Patients With Progressive or Recurrent Glioblastoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael Weller, Prof. Dr.
University of Zurich
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Landesnervenklinik Wagner-Jauregg
Linz, Austria
- Medical University Vienna, Department of Internal Medicine I
Vienna, Austria
- Charite, Department of Neurosurgery
Berlin, Germany
- Knappschaftskrankenhaus, Department of Neurology
Bochum, Germany
- University Hospital Bonn, Department of Neurology
Bonn, Germany
- Klinik Für Allgemeine Neurochirurgie
Cologne, Germany
- University Hospital Düsseldorf
Düsseldorf, Germany
- Klinikum Der Johann-Wolfgang Von Goethe-Universität, Dr. Senckenbergisches Institut Für Neuroonkologie, Zentrum Für Neurologie Und Neurochirurgie
Frankfurt, Germany
- University Hospital Freiburg
Freiburg im Breisgau, Germany
- University Hospital Heidelberg, Department of Neurooncology
Heidelberg, Germany
- Saarland University, Department of Neurosurgery
Homburg/ Saar, Germany
- Klinik Und Poliklinik Für Neurochirurgie
Leipzig, Germany
- Ludwig Maximilians University of Munich , Grosshadern Hospital, Department of Neurosurgery
Munich, Germany
- University of Regensburg, Department of Neurology
Regensburg, Germany
- University Hospital Zurich, Department of Neurology
Zurich, CH, Switzerland
- Centre Hospitalier Universitaire Vaudois and University of Lausanne
Lausanne, Switzerland
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2009
- Primary completion
- 30 Jun 2013
- Completion
- 30 Jun 2013
- Last update posted
- 15 Aug 2014
- Registered enrollment
- 105
- Registry id
- NCT00941460
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.